A real-life study of the positive response to DAA-based therapies for hepatitis C in Brazil

A retrospective cohort of 11,308 chronic hepatitis C infected patients treated with regimens that included Sofosbuvir (SOF), Daclatasvir (DCV), Simeprevir (SMV), or an association of Ombitasvir, Veruprevir/Ritonavir and Dasabuvir (3D) with or without Ribavirin (RBV) were assessed for sustained virol...

Descripción completa

Detalles Bibliográficos
Autores principales: Vivaldini, Simone Monzani, Ribeiro, Rachel Abraão, Mosimann Júnior, Gláucio, Tonini, Karen Cristine, Pereira, Gerson Fernando Mendes, Araújo, Wildo Navegantes de
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392166/
https://www.ncbi.nlm.nih.gov/pubmed/33836175
http://dx.doi.org/10.1016/j.bjid.2021.101573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392166/
https://www.ncbi.nlm.nih.gov/pubmed/33836175
http://dx.doi.org/10.1016/j.bjid.2021.101573

Ejemplares similares